Gilead Research Scholars

Organization
Gilead
Type
Pharmaceutical
Application Due Date
11-13-2026
Brief Description

Awards Supported

Gilead Sciences will be supporting a minimum of 3 awards through this program. Each awardee will receive $180,000 that will be paid directly to the scholars institution.

This program is designed to support any basic or clinical research limited to breast, endometrial, ovarian, or small cell lung cancer that addreses any unmet medical need in the field of Oncology Solid Tumors.